Pathway Capital Management, LP Kura Oncology, Inc. Put Options Transaction History
Pathway Capital Management, LP
- $107 Million
- Q1 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding KURA
# of Institutions
173Shares Held
80.9MCall Options Held
914KPut Options Held
120K-
Suvretta Capital Management, LLC New York, NY7.07MShares$149 Million6.46% of portfolio
-
Black Rock Inc. New York, NY6.9MShares$145 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$122 Million3.53% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$114 Million2.38% of portfolio
-
Bvf Inc San Francisco, CA4.79MShares$101 Million3.06% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.41B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...